Glesatinib
id:
glesatinib-180-7727909
title:
Glesatinib
text:
Glesatinib (MGCD265) is an experimental anti-cancer drug. It is in phase 2 clinical trials for non-small cell lung cancer (NSCLC). It is a spectrum selective tyrosine kinase inhibitor "for the treatment of non-small cell lung cancer (NSCLC) patients with genetic alterations of MET".
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Glesatinib
date created:
2017-01-15T13:17:42Z
date modified:
2024-09-05T10:34:42Z
main entity:
{"identifier":"Q27895580","url":"https://www.wikidata.org/entity/Q27895580"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/cb/Glesatinib_skeletal.svg","width":512,"height":252}
fields total:
13
integrity:
16